These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23329226)

  • 1. Refractory gastroesophageal reflux disease.
    Moraes-Filho JP
    Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory Heartburn: A Challenging Problem in Clinical Practice.
    Domingues G; Moraes-Filho JPP; Fass R
    Dig Dis Sci; 2018 Mar; 63(3):577-582. PubMed ID: 29352757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
    Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
    Spechler SJ
    Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to manage refractory GERD.
    Richter JE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):658-64. PubMed ID: 18043675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
    Freston JW
    Am J Med; 2004 Sep; 117 Suppl 5A():14S-22S. PubMed ID: 15478848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory GERD: what is it?
    Fass R; Gasiorowska A
    Curr Gastroenterol Rep; 2008 Jun; 10(3):252-7. PubMed ID: 18625135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ; Salas M; Ward A
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Diagnosis of GERD.
    Jeong ID
    Korean J Gastroenterol; 2017 Feb; 69(2):96-101. PubMed ID: 28239077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastroesophageal Reflux Disease].
    Park CH; Lee SK
    Korean J Gastroenterol; 2019 Feb; 73(2):70-76. PubMed ID: 30845382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory gastroesophageal reflux disease: advances and treatment.
    Ates F; Francis DO; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):657-67. PubMed ID: 24745809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of proton pump inhibitors.
    Der G
    Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease.
    Zerbib F; Bredenoord AJ; Fass R; Kahrilas PJ; Roman S; Savarino E; Sifrim D; Vaezi M; Yadlapati R; Gyawali CP
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14075. PubMed ID: 33368919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
    Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.